119 related articles for article (PubMed ID: 4653588)
1. Volatile phenols in serum of uraemic patients.
Wengle B; Hellström K
Clin Sci; 1972 Oct; 43(4):493-8. PubMed ID: 4653588
[No Abstract] [Full Text] [Related]
2. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.
Niwa T
Clin Chem; 1993 Jan; 39(1):108-11. PubMed ID: 8419031
[TBL] [Abstract][Full Text] [Related]
3. A gas chromatographic technique for the analysis of volatile phenols in serum.
Wengle B; Hellström K
Scand J Clin Lab Invest; 1971 Dec; 28(4):477-83. PubMed ID: 5157048
[No Abstract] [Full Text] [Related]
4. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
[TBL] [Abstract][Full Text] [Related]
5. The significance of serum creatinine and the blood urea-serum creatinine ratio in azotaemia.
Kahn S; Sagel J; Eales L; Rabkin R
S Afr Med J; 1972 Nov; 46(47):1828-32. PubMed ID: 4539756
[No Abstract] [Full Text] [Related]
6. A gas chromatographic-mass spectrometric analysis for phenols in uremic serum.
Niwa T; Maeda K; Ohki T; Saito A; Kobayashi K
Clin Chim Acta; 1981 Feb; 110(1):51-7. PubMed ID: 7214714
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.
Niwa T; Ise M; Miyazaki T; Meada K
Nephron; 1993; 65(1):82-7. PubMed ID: 8413797
[TBL] [Abstract][Full Text] [Related]
8. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
[TBL] [Abstract][Full Text] [Related]
9. Carbamylated haemoglobin in normal, diabetic and uraemic patients.
Kwan JT; Carr EC; Barron JL; Bending MR
Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():206-9. PubMed ID: 1626926
[TBL] [Abstract][Full Text] [Related]
10. In-vitro assessment of the removal of phenols by ACAC hemoperfusion.
Kaziuka EN; Chang TM
Int J Artif Organs; 1979 Jul; 2(4):215-21. PubMed ID: 457306
[TBL] [Abstract][Full Text] [Related]
11. Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients.
Pietrzak I; Baczyk K; Ksiazek P
Ann Univ Mariae Curie Sklodowska Med; 1995; 50():197-203. PubMed ID: 9263507
[No Abstract] [Full Text] [Related]
12. Utilization of adsorbing materials for uremic blood purification.
Denti E
Biomater Med Devices Artif Organs; 1974; 2(3):295-300. PubMed ID: 4458819
[No Abstract] [Full Text] [Related]
13. Benzyl alcohol: high levels found in plasma of uremic patients on hemodialysis.
Bowen D; Cowburn D; Rennekamp M; Sullivan J
Clin Chim Acta; 1975 Jun; 61(3):399-401. PubMed ID: 1149261
[No Abstract] [Full Text] [Related]
14. Hemoperfusion results in uremia.
Gelfand MC; Winchester JF
Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
[No Abstract] [Full Text] [Related]
15. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
[No Abstract] [Full Text] [Related]
16. Uremic middle molecules.
Bergström J; Fürst P
Clin Nephrol; 1976 Apr; 5(4):143-52. PubMed ID: 1277596
[No Abstract] [Full Text] [Related]
17. The importance of bisphenol A, an uraemic toxin from exogenous sources, in haemodialysis patients.
Mas S; Egido J; González-Parra E;
Nefrologia; 2017; 37(3):229-234. PubMed ID: 28392019
[No Abstract] [Full Text] [Related]
18. The removal of protein-bound solutes by dialysis.
Meyer TW
J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
[TBL] [Abstract][Full Text] [Related]
19. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay.
Calaf R; Cerini C; Génovésio C; Verhaeghe P; Jourde-Chiche N; Bergé-Lefranc D; Gondouin B; Dou L; Morange S; Argilés A; Rathelot P; Dignat-George F; Brunet P; Charpiot P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2281-6. PubMed ID: 21727042
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.
Hida M; Aiba Y; Sawamura S; Suzuki N; Satoh T; Koga Y
Nephron; 1996; 74(2):349-55. PubMed ID: 8893154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
